Name
Topotecan
Alternate Names
11C topotecan
Hycamtin
SKF-104864
Topotecan Hydrochloride
Abbreviations
SKFS
Category
Chemotherapy
Subcategory
Topoisomerase inhibitor
NSC Number
609699
Primary Site
Histology
None
Remarks
Phase II (colorectal, NSCLC) Phase II/III SCLC Phase III MDS, ovarian Topoisomerase I inhibitor. FDA approved use on small cell lung cancer and ovarian cancer. GlaxoSmithKline.
Coding
This drug should be coded